Cancer biology: Keeping bad company
Work at A*STAR that is unlocking the mechanisms that drive invasive tumor growth and metastasis could give new hope to cancer patients. Credit: iStockphoto.com/Thinkstock
The p53 tumor suppressor protein manages DNA repair mechanisms in response to genetic damage and kills off precancerous cells before they multiply. The loss of p53 due to mutation greatly increases risk of tumorigenesis. Even worse, however, are the various 'missense' mutations that change the amino acid sequence of p53: they warp its function to promote rather than prevent cancer.
"Mutated forms of p53 are found in 50% of human cancers," says Jayantha Gunaratne of the A*STAR Institute of Molecular and Cell Biology. "We hypothesized that mutant p53 proteins interact with selected proteins that do not bind to wild-type p53 to promote processes involved in cancer progression." To test this theory, Gunaratne teamed up with colleagues including David Lane, chief scientist of A*STAR and one of the initial discoverers of p53, to hunt for binding partners that specifically interact with the common p53R273H mutant.
The researchers used stable isotopes to label all the proteins in cultured cells expressing either wild-type p53 or p53R273H. Then they used a technique called mass spectrometry that enabled them to accurately catalogue the subset of proteins associated with either p53 variant. "We captured at least 15 protein binding partners specific to the p53R273H mutant," says Gunaratne. Among the most immediately interesting was a protein called nardilysin (NRD1), which is associated with the invasive growth and migratory behavior observed in aggressive cancers.
After determining that NRD1 exclusively binds p53R273H but not to other p53 mutants, Gunaratne and co-workers proceeded to explore how it specifically collaborates with this variant. By selectively reducing the expression of NRD1 in cultured cancer cells, they learned that this protein is a critical component of the invasive behavior manifested by p53R273H-expressing cells in response to a particular chemical trigger, a cellular signal called heparin-binding epidermal growth factor-like growth factor (HB-EGF). This HB-EGF-oriented invasion appears to occur via a cellular mechanism distinct from those that direct cell movement in response to other growth factors, indicating a novel biological process involving both p53R273H and NRD1 that needs further elucidation.
Abnormal production of HB-EGF manifests in a broad array of cancers. Gunaratne and co-workers are intrigued by the possibility that NRD1 might therefore represent a critical factor involved in tumor spread. "This study indicates that molecules that modulate NRD1 or other p53 mutant-specific protein partners could offer an exciting and defined therapeutic approach to reduce cancer metastasis," says Gunaratne.
More information: Coffill, C., et al. Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasion. EMBO Reports 13, 638–644 (2012). www.nature.com/emb… 201274a.html
Journal reference:
EMBO Reports
Provided by
Agency for Science, Technology and Research (A*STAR), Singapore
-
Effect of mutant p53 stability on tumorigenesis and drug design
May 15, 2008 |
not rated yet |
0
-
Cancer is a p53 protein aggregation disease
Mar 29, 2011 |
not rated yet |
0
-
Chemopreventive isothiocyanates selectively depletes mutant p53 in tumor cells
Apr 20, 2009 |
not rated yet |
0
-
Stabilizing cancer-fighting p53 can also shield a metastasis-promoter
May 22, 2008 |
not rated yet |
0
-
Drug kills cancer cells by restoring faulty tumor suppressor
May 14, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
14 hours ago
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
New colonoscope provides ground-breaking view of colon
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
Cancer
7 hours ago |
5 / 5 (1) |
0
ASCO: combo antibody therapy effective for melanoma
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer
May 17, 2013 |
not rated yet |
0
Risk factors ID'd for poor cutaneous cell CA outcomes
(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...
Cancer
May 17, 2013 |
not rated yet |
0
|
Physical & emotional impairments common, often untreated in people with cancer
A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system. Writing in CA: A Cancer Journal for Clinicians, Julie Silver, M.D., associate professor at Harvar ...
Cancer
May 17, 2013 |
not rated yet |
0
Calif. doc with 'cancer cure' gets 14 years prison (Update)
(AP)—A California doctor has been sentenced to 14 years in federal prison for bilking her patients out of more than $1 million by promising that an herbal supplement could cure late-stage cancer and other diseases.
Cancer
May 17, 2013 |
not rated yet |
0
New research identifies risks, interventions for children's GI health
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
US psychiatry gets makeover in new manual
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
New case of SARS-like virus in Saudi: ministry
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
AIDS science at 30: 'Cure' now part of lexicon
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
Flesh-eating disease victim gets prosthetic hands
(AP)—A woman who lost both hands, her left leg and right foot after contracting a flesh-eating disease has been fitted with prosthetic hands.